⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS
globenewswire.com
NVS
CRIS
Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics
globenewswire.com
ALNY
IONS
SRPT
BIIB
NVS
AZN
NVO
SNY
ARWR
Single-Use Bioprocessing Connectors Market Set for Robust Growth Through 2033 as Biopharma Manufacturers Prioritize Flexible, Contamination-Reducing Systems
globenewswire.com
TMO
AVTR
AMGN
BMY
LLY
NVS
AZN
GILD
REGN
BIIB
VRTX
ISRG
MDLZ
DHR
AVB
ENGS
ENTG
Cell and Gene Therapies for Rare Disorders Poised for Breakthrough Growth Through 2036, Fueled by Innovation, Expanding Pipelines and Unmet Patient Needs
globenewswire.com
CSL
SANG
CAPR
SPRC
NVS
Red Biotechnology Market Set for Robust Growth Through 2035, Fueled by Precision Medicine, Gene Therapies and Biopharmaceutical Innovation
globenewswire.com
PFE
BIIB
AMGN
AZN
GILD
MRK
BMY
REGN
LLY
NVS
BMRN
AMTX
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Novartis AG (NVS) And Encourages Stockholders to Reach Out
accessnewswire.com
NVS
Orphan Drugs Market - Global Forecast 2026-2032 Now Available, Analyzes Biologics, Gene Therapy, Small Molecules, and Tissue Therapy
globenewswire.com
ABBV
ALNY
AMGN
BMRA
BMY
GILD
INCY
JNJ
NVS
PFE
REGN
VRTX
Drug Discovery Technologies Market - Global Forecast 2026-2032
globenewswire.com
ABT
AMGN
AZN
BIO
BMY
GEHC
GILD
ILMN
IQV
MRK
NVS
PFE
SNY
TMO
Bronstein, Gewirtz & Grossman, LLC Is Investigating Novartis AG (NVS) And Encourages Stockholders to Connect
accessnewswire.com
NVS
Big Pharma Setbacks Create a New Wave of Rebound Plays
globenewswire.com
NVS
NTHI
TNON
IRD